DrugPatentWatch Database Preview

Akorn Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?

AKORN has one hundred and sixty-eight approved drugs.

There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.

There are two patent family members on AKORN drugs in two countries and one hundred and fifty-two supplementary protection certificates in twelve countries.

Summary for Akorn

International Patents:	2
US Patents:	1
Tradenames:	133
Ingredients:	122
NDAs:	168
Patent Litigation for Akorn:	See patent lawsuits for Akorn
PTAB Cases with Akorn as petitioner:	See PTAB cases with Akorn as petitioner

Drugs and US Patents for Akorn

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	TRANEXAMIC ACID	tranexamic acid	INJECTABLE;INJECTION	206634-001	Jun 9, 2016	AP	RX	No	No
Akorn	ERYTHROMYCIN	erythromycin	SWAB;TOPICAL	090215-001	May 12, 2010	AT	RX	No	No
Akorn	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	INJECTABLE;INJECTION	083955-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Akorn	ATROPINE SULFATE	atropine sulfate	SOLUTION/DROPS;OPHTHALMIC	206289-001	Jul 18, 2014		RX	Yes	Yes
Akorn Inc	ACETYLCYSTEINE	acetylcysteine	INJECTABLE;INTRAVENOUS	203173-001	Mar 24, 2015	AP	RX	No	No

Expired US Patents for Akorn

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Akorn	ALFENTA	alfentanil hydrochloride	INJECTABLE;INJECTION	019353-001	Dec 29, 1986	4,167,574
Akorn	SUFENTA PRESERVATIVE FREE	sufentanil citrate	INJECTABLE;INJECTION	019050-001	May 4, 1984	3,998,834

International Patents for Akorn Drugs

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008014036
European Patent Office	2043601

Supplementary Protection Certificates for Akorn Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
00653	Netherlands		PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906
C0013	France		PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
462	Luxembourg		PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225
00C/032	Belgium		PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
C0067	France		PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Akorn
• Akorn Inc
• Akorn Mfg